Feb 4, 2026
Caplyta
(lumateperone) is an atypical antipsychotic approved by the initially in December 2019 for schizophrenia and later for bipolar depression; it is also indicated as adjunctive therapy for major depressi...
Dementia-Related Psychosis
The increased mortality risk in elderly patients with dementia-related psychosis associated with antipsychotic medications.